[1]
F. Caprioli, M. C. Fantini, F. Marando, D. Scaduto, and R. Ravasio, “Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis”, Grhta, vol. 11, no. 1, pp. 55–67, Mar. 2024.